Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |